Pfizer Earnings Miss Follows Amgen: Is Merck Next?
Drug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock is down more than 3%. Last week competitor Amgen Inc. ...Read Full Story »




